Single comment threadYou are looking at one branch of my ApoB moved and I cannot work out whether method development is why — 47 comments in the full submission. View in context.
2k
my ApoB moved and I cannot work out whether method development is why
gradient. That is the whole post, but I will justify it. Everything else people worry about in c/dosinglogs is downstream of it. Titration speed, muscle cramps, the endless dose arguments — most of it resolves if you sort gradient out first, and almost nobody does. I say this having got it wrong for 23 months. My…
You have restated the marketing copy. What is the actual substance here.
[removed]25 points·1 year ago
[removed by moderator]
Disagree. What you are describing is consistent with gradient, not with what you concluded.
Small correction: the trial was 23 weeks, not 27. Does not change your point but people will quote it.
Did they post the raw trace or just the summary?
chromatogram or it did not happen
related substances are where the story lives, not the main peak